Characterization of early-stage lung cancer patients and biomarkers in Colombia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses medical chart reviews to characterize patients with resectable NSCLC stages IA–IIIB in Colombia. It aims to describe biomarker profiles, health resource utilization, and related outcomes, considering the country’s insurance structure and possible care fragmentation. The study will summarize clinical characteristics, available biomarker data, and patterns of care across public and private insurance regimes. Data will be analyzed to identify associations between resources used and potential differences in care delivery and outcomes. No intervention is administered; the study relies on existing records.

Why it matters

Who can join: the full rules

Inclusion Criteria:

All inclusion and exclusion criteria will be reviewed by the investigator or qualified designee to ensure that the subject qualifies for the study.

1. Patients ≥ 18 years old
2. Patients diagnosed with NSCLC (stage IA, IB, II, IIIA, and IIIB)
3. Clinical records available

Exclusion Criteria:

1. Patients with another primary tumor diagnosed (synchronic tumor)
2. Patients from insurances regimens other than the public and private system.
3. Patients with advanced/metastatic disease
4. Patients diagnosed with resectable stage IA, IB, II, IIIA, and IIIB NSCLC in Colombia that went under immunotherapy treatment

Where it's running

• Hospital Universitario San Ignacio
  Bogotá, Colombia Recruiting

Study contacts

• Principal investigator: Raúl Murillo, Dr — Hospital Universitario San Ignacio
• Study coordinator: Raúl Murillo, Dr
• Email: rmurillo@husi.org.co
• Phone: +57 (601) 5946161

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

• Olive oil before lung cancer surgery to see if it lowers chylothorax

  This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.

  Recruiting Fudan University · Shanghai, Xuhui · NCT07807696

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.